REDWOOD CITY, Calif., Sept. 19, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on September 7, 2024, the Compensation Committee of the Company's...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Seaking AlphaSeeking Alpha / Seaking Alpha 7 hours ago 1 Views
Comments